Towards Healthcare
AAV Vector CDMO Services Market to Grow at 15.24% CAGR till 2034

AAV Vector CDMO Services Market Poised for Global Expansion

The global AAV vector CDMO services market was valued at USD 9.84 billion in 2024 and is projected to reach USD 25.36 billion by 2034, growing at a CAGR of 9.75%. North America led with 38% share, followed by Europe (29%) and Asia-Pacific (23%). The report covers service type, container format, scale, and end-user segments, along with value chain, trade, and supplier data. It also includes insights into 60+ manufacturers, competitive strategies, and technological innovations shaping global market growth.

Content

  • Last Updated: 17 October 2025
  • Report Covered: [Revenue + Volume]
  • Historical Year: 2021-2023
  • Base Year: 2024
  • Estimated Years: 2025-2034

About The Author

Deepa Pandey is a focused and detail-oriented market research professional with growing expertise in the healthcare sector, delivering high-quality insights across therapeutic areas, diagnostics, biotechnology, and healthcare services.

She began her research career at Precedence Research, where she contributed to a wide range of healthcare industry studies, helping build a strong foundation in market intelligence and strategic research. Currently, Deepa plays a critical role at Towards Healthcare, while also extending her research capabilities across Statifacts, supporting cross-industry intelligence initiatives with a focus on healthcare.

Her ability to distill complexity into clarity has made her a trusted contributor to both internal teams and external clients across the healthcare value chain. By combining professionalism with an evolving depth in healthcare research, Deepa consistently adds value to projects that demand critical thinking, market precision, and industry-specific knowledge. Her contributions help organizations navigate the complexities of regulated markets and make data-backed growth decisions.

Talk to us
FAQ's

The AAV vector CDMO services market stands at USD 1.43 billion in 2025 and is expected to reach USD 5.14 billion by 2034, growing at a CAGR of 15.24% from 2024 to 2034.

North America is leading the AAV vector CDMO services market share by 42% due to the availability of state-of-the-art research and development facilities, favorable regulatory policies, and the presence of key players.

The AAV vector CDMO services market includes 6 segments by service type, by scale of operation, by vector serotype, by therapeutic area, by end-user, and by region.

AAV is a versatile viral vector technology that can be engineered to deliver gene therapy products within the body.

National Institute of Health, Food and Drug Administration, Government of Canada, Press Information Bureau
Any Questions